Cancer of Unknown Primary
Authors:
- 1 January 2008
- book chapter
- Published by Springer Nature
- Vol. 170, 193-202
Abstract
Cancer of unknown primary (CUP) is defined as malignancy without known origin at the time of the initial diagnosis, thus representing a heterogeneous group of tumors with varying clinical features. Between 0.5% and 7% of all cancer patients are diagnosed with cancer of an unknown primary tumor ( van de Wous et al. 2002 ). Detected primary revealed lung cancer most often, followed by oropharynx carcinoma, nasopharynx, breast, colorectal, and esophagus carcinoma ( Delgado-Bolton et al. 2003 ). Overall the primary tumor in CUP patients is detected in less than 40% of the patients by conventional diagnostic procedures, frequently after having performed many examinations in all patients. Moreover, even with autopsy the primary could only be detected in approximately 80%. Hypothesized reasons are a metastatic phenotype with a small size of the primary due to involution during the course of disease or an extremely slow growth rate, but none of the biological hypotheses is confirmed by results from the literature ( Van de Wouw et al. 2003 ).Keywords
This publication has 42 references indexed in Scilit:
- Respiration artifacts in whole-body 18F-FDG PET/CT studies with combined PET/CT tomographs employing spiral CT technology with 1 to 16 detector rowsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2005
- Accuracy of Whole-Body Dual-Modality Fluorine-18–2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) for Tumor Staging in Solid Tumors: Comparison With CT and PETJournal of Clinical Oncology, 2004
- Dual-Modality PET/CT Scanning with Negative Oral Contrast Agent to Avoid Artifacts: Introduction and EvaluationRadiology, 2004
- 18FDG-PET in 733 consecutive patients with or without side-by-side CT evaluationNuklearmedizin-Nuclear Medicine, 2004
- Whole-Body Dual-Modality PET/CT and Whole-Body MRI for Tumor Staging in OncologyJAMA, 2003
- Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumours (CUP syndrome)Nuclear Medicine Communications, 2003
- PET-CT: accuracy of PET and CT spatial registration of lung lesionsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncologyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Metastatic Head and Neck Cancer: Role and Usefulness of FDG PET in Locating Occult Primary TumorsRadiology, 1999
- Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients.Journal of Clinical Oncology, 1994